By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Media HydeMedia Hyde
  • Home
  • Politics
  • Education
  • Entertainment
  • Sports
  • Blogs
  • Business & Commerce
  • Others
    • Religious
    • Metropolitan
    • Climate and Weather
Font ResizerAa
Media HydeMedia Hyde
Font ResizerAa
  • Home
  • Politics
  • Education
  • Entertainment
  • Sports
  • Blogs
  • Business & Commerce
  • Others
    • Religious
    • Metropolitan
    • Climate and Weather
Follow US
© 2026 Media Hyde Network. All Rights Reserved.
Health

YAP1 Protein Identified as Key Driver of Chemotherapy Resistance in Lung Cancer Small cell lung cancer

Last updated: May 6, 2026 11:08 pm
Misbah Jogyat
Share
YAP1 Protein Identified as Key Driver of Chemotherapy Resistance in Lung Cancer Small cell lung cancer
YAP1 Protein Identified as Key Driver of Chemotherapy Resistance in Lung Cancer Small cell lung cancer
SHARE

(SCLC) patients often face a grim reality  initial chemotherapy works, but the cancer almost always returns, fueled by aggressive, drug-resistant cells. New research has pinpointed a specific protein, YAP1, as the primary engine behind this survival mechanism.

The findings, published in the latest issue of Cancer Cell, explain why standard platinum-based treatments eventually fail. Researchers found that when SCLC cells are exposed to chemotherapy, they don’t just die the survivors undergo a molecular shift. They activate the YAP1 protein, which essentially reprograms the cell to bypass the damage caused by the drugs.

“We aren’t just looking at random mutations,” said Dr. Elena Rossi, lead author of the study.

“We’re looking at a survival switch. Once YAP1 is turned on, the cancer cells stop acting like typical lung cells and start behaving like highly resilient stem cells.” This shift makes the tumor nearly impervious to standard therapy. The research team used CRISPR gene editing technology to disable the YAP1 protein in lab-grown SCLC models.

The result was immediate: the cells lost their resistance and became sensitive to chemotherapy once again. The clinical implications are sharp. Current treatment protocols for SCLC haven’t changed significantly in decades, largely because the disease is so adept at evading destruction.

Targeting YAP1 could provide a way to “re-sensitize” tumors, potentially allowing existing drugs to finish the job they currently cannot.

However, the path to a human treatment remains complex. YAP1 is active in many healthy tissues, meaning a systemic drug could trigger severe side effects. The next hurdle for the team is developing a targeted delivery mechanism something that hits the tumor’s YAP1 expression without damaging the rest of the patient’s body.

Until then, the study provides a clear roadmap for researchers: stop the protein, stop the relapse. For patients currently facing the high recurrence rates of SCLC, this offers the first concrete target for a new generation of combination therapies.

Share This Article
Email Copy Link Print
Previous Article Bushra Bibi moved to private hospital in Rawalpindi for eye treatment
Next Article The War on Mosquitoes: Why Science is Failing to Kill the Buzz The War on Mosquitoes: Why Science is Failing to Kill the Buzz
Leave a Comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Sponsored Ads

Stay Connected

FacebookLike
XFollow
InstagramFollow
YoutubeSubscribe
WhatsAppFollow
ThreadsFollow
Panchayat Season 5 Release Date Announced Jitendra Kumar and Neena Gupta Return to Phulera
Panchayat Season 5 Release Date Announced Jitendra Kumar and Neena Gupta Return to Phulera
Entertainment
November 18, 2026
Nameer Khan Reveals His Journey from Software Engineer to Actor
Nameer Khan Reveals His Journey from Software Engineer to Actor
Entertainment
November 18, 2026
Aiman Khan and Muneeb Butt Honoured at British Parliament
Aiman Khan and Muneeb Butt Honoured at British Parliament
Entertainment
November 18, 2026
PTI Questions Bilawal Bhutto-Zardari Over Late Realisation of Public Hardships
PTI Questions Bilawal Bhutto-Zardari Over Late Realisation of Public Hardships
Politics
November 18, 2026
Nawaz Sharif Vows to Accelerate Development in Azad Kashmir Under 100-Day Plan
Nawaz Sharif Vows to Accelerate Development in Azad Kashmir Under 100-Day Plan
Politics
November 18, 2026
Pakistan faces internet slowdown after submarine cable develops fault
Pakistan faces internet slowdown after submarine cable develops fault
Headline Technology
November 18, 2026

You Might Also Like

Health

Medical and Dental Colleges Nationwide Directed to Implement Mental Health Screening

By
Neha Ashraf
Health

Weight Loss Improves Immune System and Reduces Cancer Risk

By
Neha Ashraf
Health

Levies Officer Martyred in Firing on Polio Team in Swat

By
Neha Ashraf
Health

Karachi Hospital Sealed After Infant Mpox Case Raises Negligence Concerns

By
Syed Jarri Abbas
Media Hyde Media Hyde Dark
Facebook Twitter Youtube Rss Medium

About US

Media Hyde Network: Your instant connection to breaking stories and live updates. Stay informed with our real-time coverage across politics, tech, entertainment, and more. Your reliable source for 24/7 News.

Top Categories
  • Headline
  • Politics
  • Entertainment
  • Education
  • Sports
  • Religious
  • Metropolitan
  • Climate and Weather
Usefull Links
  • Contact Us
  • Disclaimer
  • Privacy Policy
  • Cookies Policy
  • Advertising Policy
  • Terms & Conditions

© 2025 Media Hyde Network. All Rights Reserved.

Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?